G20 I63 I64
Conditions
Interventions
Group 1: The Kölner Agnosie-Diagnostikum (KAD) will be implemented in a healthy sample to collect data for the calculation of normative values. The healthy sample consists of 100 participants (w=50, m
DemTect), depression and a sociodemographic questionnaire will be implemented to ensure that the results in the KAD cannot be explained by cognitive impairment or depression.
Group 2: The Kölner Agn
DemTect), depression and a sociodemographic questionnaire will be implemented to ensure that the results in the KAD cannot be explained by cognitive impairment or depression.
Sponsors
AG Neuropsychologie Uniklinik Köln
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: age: 18-90; female and male; German language proficiency; written declaration of consent of the participant; normal or corrected vision and normal or corrected hearing; clinical sample: patients who suffer from Parkinson’s disease (stages II-III according to Hoahn & Yahr) or who had an ischemic attack in a period of four weeks before test date
Exclusion criteria
Exclusion criteria: Impaired vision or hearing; clinically relevant depressive symptoms; current or retrospective alcohol- or drug abuse; existence of impaired cognitive functions that may influence the test results (DemTect =9)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Development of the new psychometric Kölner-Agnosie Diagnostikum (KAD). Comparison of the two samples to define the normative values. Correlation of the test results of the KAD with well-established tests for cognitive functions (MMST;DemTect), a sociodemographic questionnaire and an inventory for the diagnostics of depressive symptoms (BDI-IV). ROC-curve Analysis to determinate the sensitivity and specificity of the test. | — |
Countries
Germany
Contacts
Public ContactJosef Kessler
AG Neuropsychologie Uniklinik Köln
Outcome results
None listed